Medindia

X

ReachMD and VerusMed Broadcast Medical Conference Coverage on XM Satellite Radio

Thursday, February 7, 2008 General News J E 4
Advertisement
CHICAGO and NASHVILLE, Tenn., Feb. 6 VerusMed and ReachMD,providers of advanced health care news and information for medicalprofessionals, today announced a partnership to provide VerusMed's medicalconference coverage highlights on ReachMD XM Satellite Radio (Channel 157) andvia online streaming audio and on-demand podcasts. The companies willcollaborate to deliver updated conference coverage 24/7 to physicians.

The new conference series includes coverage of rheumatology, psychiatryand other therapeutic areas. Conference coverage will be aired daily in four,13-minute audio segments. The programs include interviews, thought leaderperspectives and peer insights on news released from the conference.

"We're thrilled to be partnering with ReachMD to expand our clinical newsbriefings to physicians in another convenient information channel," said ScottMcQuigg, CEO of VerusMed, a ConnectivHealth company. "For busy physicians,24/7 XM radio programming that can be downloaded via podcast is an ideal wayto catch up on conference coverage highlights."

Through its experienced team of medical writers and editors, VerusMeddelivers timely news coverage from key medical conferences to medicalprofessionals who need to stay current on the groundbreaking research beingconducted in their specialty areas. Each conference series will expand on keyhighlights as reported by VerusMed's editorial team.

"This partnership is a great opportunity to deliver on our vision ofgiving medical professionals updated news from the nation's top medicalconferences," said Gary Epstein, CEO of ReachMD. "VerusMed is an invaluablesource of medical conference coverage for on-the-go medical professionals, andwe share the same commitment to deliver much needed information in the mostconvenient ways."

VerusMed's coverage will also be archived on ReachMD's website for oneyear after each conference airing.

About VerusMed

VerusMed, an evolution of Faxwatch, provides timely, unbiased medicalinformation to physicians, health care professionals, industry executives andpatients. With its concise and objective editorial approach, VerusMed ensuresthat physicians and health care professionals receive the most relevanttherapeutic updates. With more than 150,000 readers across several dozentherapeutic and industry segment-specific publications, VerusMed is able toleverage its market connectivity to help companies in the pharmaceutical,biotechnology, hospital and managed care industries to establish brands andbuild rapport with key audiences. VerusMed is a ConnectivHealth company. Tolearn more, visit www.verusmed.com.

About ReachMD

ReachMD, headquartered in Highland Park, Illinois, is a leading providerof advanced healthcare information and education for medical professionals.ReachMD XM 157 remains committed to its mission of delivering highly relevanteducation, information and communication to medical professionals. The ReachMDXM channel is a new and innovative media vehicle that continues to deliver onthis mission. The company's proprietary technology provides the mostup-to-date healthcare information in the field through a multi-channelplatform that includes satellite radio and online programs accessed throughany XM radio, digital media device or PC. Through this platform, healthcareprofessionals receive the latest information in best practices and newadvances in treatment, delivered through convenient and accessible ways. Formore information, visit www.reachmd.com.For more information, contact: Michelle Ponte, Communications Director VerusMed, a ConnectivHealth company 615-345-9467 michelle.ponte@connectivhealth.com Nina Velasquez for ReachMD Kwittken & Company 646-747-7161 nvelasquez@kwitco.com

SOURCE ReachMD; VerusMed
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Barr Launches Generic Fosamax(R) Tablets, 70 mg
S
Agatston Research Foundation Sponsors New Childhoo...